Sabra Health Care REIT, Inc. Aktie News

NAV Monitor: U.S. REITs End January At Median 16.2% Discount To Net Asset Value

REITs are positioned for robust growth in 2026, driven by decelerating supply, disciplined capital allocation, and significant valuation discounts to NAV and private markets. Sector preferences favor Healthcare and Data Centers for durable growth, with Shopping Centers and select Residential REITs offering underappreciated upside and private capital interest. Strategic alternatives, buybacks, a...

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 fourth quarter earnings release on February 12, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 fourth quarter results will be held on Friday, February 13 at 11:00 a.m. Pacific Time. The dial-in number for U....

Sabra Health Care REIT is rated Buy, with substantial upside driven by its accelerated transition to the SHOP operating model and attractive valuation. SBRA targets 40% SHOP portfolio exposure, expecting to exceed their up to $500M investment guidance, positioning for robust growth into 2026. Normalized AFFO guidance for 2025 is $1.495/share, with an 80% payout ratio supporting a 6.38% dividend...

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2025tax--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share   Total Ordinary Dividends   Non-...

TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. Mr. Smith succeeds Talya Nevo-Hacohen, Sabra's former Chief Investment Officer, Treasurer and Executive Vice President in connection with her ...

My update on Sabra Health Care REIT upgrades it to a strong buy. Although technical indicators point to a hold, several fundamentals drive the needle into the highly bullish range, particularly portfolio growth and macro demand in this niche of senior care. AFFO dividend coverage is adequate, though the payout ratio is slightly elevated at around 81%.

Sabra Health Care REIT presents a compelling value-income opportunity, offering a 6.4% yield and robust fundamentals. SBRA's SHOP segment drives growth, with same-store NOI up 13.3% and significant new investments targeting a 40% SHOP NOI mix. It received an investment-grade rating, has safe leverage, and has no debt maturities until 2027, supporting dividend safety.